top of page

Scientific studies on mRNA

Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration

Dermatology

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination

Dermatology

Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination

Dermatology

Pityriasis rosea after Moderna mRNA-1273 vaccine, A case series

Dermatology

Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination, a report of five cases and review of the literature

Dermatology

Pityriasis Rosea Associated With COVID-19 Vaccination, A Common Rash Following Administration of a Novel Vaccine

Dermatology

Pityriasis rosea developing after COVID-19 vaccination

Dermatology

Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl

Dermatology

Pityriasis rosea following SARS-CoV-2 vaccination, A case series

Dermatology

Pityriasis rosea, pityriasis rosea-like eruptions and herpes zoster after covid-19 and covid-19 vaccination

Dermatology

Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination 35yoM

Dermatology

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine

Dermatology

Pityriasis rubra pilaris after COVID-19 vaccination, causal relationship or coincidence

Dermatology

Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination, A Case Report and Literature Review

Dermatology

Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine

Dermatology

Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine

Dermatology

Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura

Dermatology

Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male

Dermatology

Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as Mechanism

Dermatology

Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination

Dermatology
bottom of page